Showing results (231-240 of 527) with videos related to

Sort By:
Pageof 53
World Journal of Surgery|July 27, 2016
Natural History of Pneumoperitoneum After Laparotomy: Findings on Multidetector-Row Computed TomographyBrice Malgras, Vinciane Placé, Anthony Dohan, et al.
Critical Reviews in Oncology/Hematology|November 2, 2010
Imaging of malignant neoplasms of the mesenteric small bowel: new trends and perspectivesPhilippe Soyer, Mourad Boudiaf, Elliot K Fishman, et al.
European Journal of Radiology|May 30, 2015
Intrahepatic and hilar mass-forming cholangiocarcinoma: Qualitative and quantitative evaluation with diffusion-weighted MR imagingHassan El Fattach, Anthony Dohan, Youcef Guerrache, et al.
European Journal of Radiology|September 29, 2019
Contribution of magnetic resonance imaging to the management of esophageal diseases: A systematic reviewChloé Leandri, Philippe Soyer, Ammar Oudjit, et al.
European Radiology|March 15, 2017
Anoperineal disease in Hidradenitis Suppurativa : MR imaging distinction from perianal Crohn's diseaseLouise Monnier, Anthony Dohan, Nedjoua Amara, et al.
Journal of Computer Assisted Tomography|January 16, 2014
Focal nodular hyperplasia of the liver: diffusion-weighted magnetic resonance imaging characteristics using high b valuesAnthony Dohan, Philippe Soyer, Youcef Guerrache, et al.
European Radiology|May 16, 2016
Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient dataTitus F M Wijnands, Maxime Ronot, Tom J G Gevers, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 18, 2022
Volumetric Analysis of Progressive Remodeling of Isolated Mesenteric Artery Dissection Treated by Conservative TherapyIannis Ben Abdallah, Damian Craiem, Mariano Casciaro, et al.
Abdominal Imaging|November 23, 2013
Magnetic resonance imaging of cystic pancreatic lesions in adults: an update in current diagnostic features and managementMatthias Barral, Philippe Soyer, Anthony Dohan, et al.
The Oncologist|March 22, 2014
Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenibMaxime Ronot, Mohamed Bouattour, Johanna Wassermann, et al.
Pageof 53